G. Papanikolaou General Hospital

Thessaloniki, Greece

Papanikolaou General Hospital of Thessaloniki has joined IASIOS as an Enrolled Centre. This step marks the beginning of their accreditation pathway and reflects the team’s commitment to aligning with internationally recognised standards in interventional oncology, with a focus on quality assurance, patient safety, and multidisciplinary cancer care.

IASIOS enrolment provides a structured framework to support continuous quality improvement and the delivery of safe, consistent, high-quality, image-guided treatments. We look forward to supporting the team as they progress towards accreditation.

Centre hospitalier de l’Université de Montréal (CHUM)

Montréal, Canada

We are proud to announce a milestone accreditation: the Centre hospitalier de l’Université de Montréal has become the first IASIOS Accredited Centre in Canada. This achievement recognises that the interventional oncology service at the facility meets internationally standardised requirements for quality assurance, patient safety, and multidisciplinary cancer care.

IASIOS accreditation reflects a commitment to structured processes, evidence-based practice, and continuous improvement in interventional oncology. It also highlights the growing role of image-guided, minimally invasive treatments in modern cancer care.

Congratulations to Prof. Ricardo Amaral and the entire interventional radiology team on reaching this important milestone and setting a benchmark for interventional oncology services in Canada.

Tirol Clinic, Medical University of Innsbruck

Innsbruck, Austria

Tirol Kliniken, Medical University of Innsbruck, has joined IASIOS as an Enrolled Centre, marking the start of its accreditation pathway and a strong commitment to high standards in interventional oncology.

By entering the IASIOS programme, the facility aligns with internationally recognised principles of quality assurance, patient safety, and multidisciplinary cancer care. IASIOS accreditation provides a structured framework for evaluation, peer review, and continuous quality improvement, supporting the delivery of safe, consistent, high-quality, image-guided treatments.

We are pleased to welcome the team and look forward to supporting their progress towards IASIOS accreditation.

ASST Niguarda Great Metropolitan Hospital

Italy, Milan

ASST Niguarda Great Metropolitan Hospital is now part of IASIOS as an Enrolled Centre, marking the beginning of its accreditation pathway and reinforcing its commitment to high standards in interventional oncology.

By joining IASIOS, the facility aligns with internationally recognised principles of quality assurance, patient safety, and multidisciplinary cancer care. IASIOS accreditation provides a structured framework for evaluation, peer review, and continuous quality improvement, supporting the delivery of safe, consistent, high-quality, image-guided treatments.

We are pleased to welcome the team and look forward to accompanying them on their path towards IASIOS accreditation.

Geneva University Hospitals

Geneva, Switzerland

Our congratulations to Geneva University Hospitals on achieving IASIOS Accredited Centre status. This recognition confirms that the interventional oncology service delivers consistent, high-quality care aligned with internationally recognised standards for quality assurance, patient safety, and multidisciplinary cancer care.

IASIOS accreditation is based on the CIRSE Standards of Quality Assurance in Interventional Oncology, providing a structured framework for clinical excellence, governance, and continuous quality improvement across the patient pathway.

We recognise Dr Alexis Ricoeur and the entire interventional radiology team for their commitment to advancing high-quality interventional oncology services and setting a strong example within the international IO community.

Mater Misericordiae University Hospital

Dublin, Ireland

Mater Misericordiae University Hospital has joined IASIOS as an Enrolled Centre, demonstrating its commitment to patient safety and high-quality clinical practice. As interventional oncology continues to be recognised as a core pillar of multidisciplinary oncology and integrated into comprehensive cancer care strategies, this step reflects a clear focus on structured, standardised care.

IASIOS provides a framework for structured evaluation, peer review, and continuous quality improvement, supporting institutions in delivering safe, consistent, high-quality interventional oncology services.

We look forward to supporting the team as they progress along the IASIOS accreditation pathway.

Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital

Ankara, Turkey

Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital has joined IASIOS as an Enrolled Centre, marking the start of its accreditation pathway and a commitment to internationally recognised standards in interventional oncology.

This step reflects a focus on quality assurance, patient safety, and multidisciplinary cancer care. IASIOS accreditation provides a structured framework for evaluation, peer review, and continuous quality improvement, supporting the delivery of safe, consistent, high-quality, image-guided treatments.

We look forward to supporting the team as they progress towards accreditation.

The Mediterranean Hospital of Cyprus

Limassol, Cyprus

The Mediterranean Hospital of Cyprus has joined IASIOS as an Enrolled Centre, becoming the first in Cyprus. This step reflects the team’s commitment to aligning with internationally recognised standards in interventional oncology, with a focus on quality assurance, patient safety, and structured, multidisciplinary cancer care.

IASIOS enrolment marks the beginning of a clear pathway towards accreditation, supporting centres in strengthening clinical practice and delivering consistent, high-quality, image-guided treatments.

We look forward to supporting the team as they progress towards accreditation.

The National Cancer Institute of Milan

Milan, Italy

We congratulate the National Cancer Institute of Milan (Fondazione IRCCS Istituto Nazionale dei Tumori di Milano) on achieving IASIOS Accredited Centre status. The facility meets the core criteria of the CIRSE Standards of Quality Assurance in Interventional Oncology, supported by more than 40 national and international societies. These standards provide a structured framework for clinical excellence, patient safety, and operational quality across the entire patient pathway.

This accreditation highlights the team’s commitment to quality assurance in interventional oncology and to delivering safe, standardised, and high-quality cancer care. We recognise Dr Alfonso Marchianò, Dr Tommaso Cascella, and the entire interventional radiology team for reaching this milestone.

IRCCS Fondazione Istituto Nazionale Tumori

Milan, Italy

We are pleased to announce that IRCCS Fondazione Istituto Nazionale Tumori in Italy has been awarded IASIOS Accredited Centre status. This recognition confirms that its interventional oncology service meets internationally established standards for quality assurance, patient safety, and multidisciplinary cancer care.

IASIOS accreditation reflects a strong institutional commitment to structured clinical processes, evidence-based practice, and the ongoing advancement of interventional oncology. It also underscores the important role of image-guided, minimally invasive therapies in delivering modern, high-quality cancer care.

Congratulations to Dr. Tommaso Cascella and team on this achievement as it marks a significant contribution to the continued development of interventional oncology standards at both national and international levels.